Literature DB >> 22106953

The crystal structure of human endoplasmic reticulum aminopeptidase 2 reveals the atomic basis for distinct roles in antigen processing.

James R Birtley1, Emmanuel Saridakis, Efstratios Stratikos, Irene M Mavridis.   

Abstract

Endoplasmic reticulum aminopeptidases ERAP1 and ERAP2 cooperate to trim a vast variety of antigenic peptide precursors to generate mature epitopes for binding to major histocompatibility class I molecules. We report here the first structure of ERAP2 determined at 3.08 Å by X-ray crystallography. On the basis of residual electron density, a lysine residue has been modeled in the active site of the enzyme; thus, the structure corresponds to an enzyme-product complex. The overall domain organization is highly similar to that of the recently determined structure of ERAP1 in its closed conformation. A large internal cavity adjacent to the catalytic site can accommodate large peptide substrates. The ERAP2 structure provides a structural explanation for the different peptide N-terminal specificities between ERAP1 and ERAP2 and suggests that such differences extend throughout the whole peptide sequence. A noncrystallographic dimer observed may constitute a model for a proposed ERAP1-ERAP2 heterodimer. Overall, the structure helps explain how two homologous aminopeptidases cooperate to process a large variety of sequences, a key property of their biological role.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22106953     DOI: 10.1021/bi201230p

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  34 in total

1.  Screening Identifies Thimerosal as a Selective Inhibitor of Endoplasmic Reticulum Aminopeptidase 1.

Authors:  Athanasios Stamogiannos; Athanasios Papakyriakou; Francois-Xavier Mauvais; Peter van Endert; Efstratios Stratikos
Journal:  ACS Med Chem Lett       Date:  2016-05-31       Impact factor: 4.345

2.  Crystal Structures of ERAP2 Complexed with Inhibitors Reveal Pharmacophore Requirements for Optimizing Inhibitor Potency.

Authors:  Anastasia Mpakali; Petros Giastas; Rebecca Deprez-Poulain; Athanasios Papakyriakou; Despoina Koumantou; Ronan Gealageas; Sofia Tsoukalidou; Dionisios Vourloumis; Irene M Mavridis; Efstratios Stratikos; Emmanuel Saridakis
Journal:  ACS Med Chem Lett       Date:  2017-02-21       Impact factor: 4.345

3.  The Human Leukocyte Antigen (HLA)-B27 Peptidome in Vivo, in Spondyloarthritis-susceptible HLA-B27 Transgenic Rats and the Effect of Erap1 Deletion.

Authors:  Eilon Barnea; Dganit Melamed Kadosh; Yael Haimovich; Nimman Satumtira; Martha L Dorris; Mylinh T Nguyen; Robert E Hammer; Tri M Tran; Robert A Colbert; Joel D Taurog; Arie Admon
Journal:  Mol Cell Proteomics       Date:  2017-02-10       Impact factor: 5.911

Review 4.  Genetic associations and functional characterization of M1 aminopeptidases and immune-mediated diseases.

Authors:  N Agrawal; M A Brown
Journal:  Genes Immun       Date:  2014-08-21       Impact factor: 2.676

Review 5.  The interplay between HLA-B27 and ERAP1/ERAP2 aminopeptidases: from anti-viral protection to spondyloarthritis.

Authors:  C Vitulano; V Tedeschi; F Paladini; R Sorrentino; M T Fiorillo
Journal:  Clin Exp Immunol       Date:  2017-08-30       Impact factor: 4.330

6.  Crystal structure of human insulin-regulated aminopeptidase with specificity for cyclic peptides.

Authors:  Stefan J Hermans; David B Ascher; Nancy C Hancock; Jessica K Holien; Belinda J Michell; Siew Yeen Chai; Craig J Morton; Michael W Parker
Journal:  Protein Sci       Date:  2014-12-26       Impact factor: 6.725

7.  Structural Basis for Antigenic Peptide Recognition and Processing by Endoplasmic Reticulum (ER) Aminopeptidase 2.

Authors:  Anastasia Mpakali; Petros Giastas; Nikolas Mathioudakis; Irene M Mavridis; Emmanuel Saridakis; Efstratios Stratikos
Journal:  J Biol Chem       Date:  2015-09-17       Impact factor: 5.157

Review 8.  Monitoring peptide processing for MHC class I molecules in the endoplasmic reticulum.

Authors:  Nilabh Shastri; Niranjana Nagarajan; Kristin C Lind; Takayuki Kanaseki
Journal:  Curr Opin Immunol       Date:  2013-12-11       Impact factor: 7.486

9.  Crystal structure of a polypeptide's C-terminus in complex with the regulatory domain of ER aminopeptidase 1.

Authors:  Lufei Sui; Amit Gandhi; Hwai-Chen Guo
Journal:  Mol Immunol       Date:  2016-11-05       Impact factor: 4.407

Review 10.  Advances in the genetics of spondyloarthritis and clinical implications.

Authors:  Darren D O'Rielly; Proton Rahman
Journal:  Curr Rheumatol Rep       Date:  2013-08       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.